|
Today's News Releases
|
Home | Submit Press Release | Advertise | Submit Website
(IndustryNews247.Com, January 05, 2017 ) Publisher's clinical trial report, "Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2016" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Publisher Clinical Trial Reports are generated using Publisher's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
For more information http://www.reportsweb.com/leishmaniasis-kala-azar-global-clinical-trials-review-h1-2016
Scope
- The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Reasons to buy
- Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001183272/sample
Companies Mentioned:
International Centre for Diarrhoeal Disease Research, Bangladesh Medecins Sans Frontieres Knight Therapeutics Inc. Aeterna Zentaris Inc. Zydus Cadila Healthcare Limited Lifecare Innovations Private Limited GVK Power and Infrastructure Limited Fast-Track Drugs & Biologics, LLC Endo International Plc Bharat Serums And Vaccines Limited
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001183272/buying.
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|
|
|
Industrial News TV
|